
Drotiphar-M Tablet
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Drotiphar-M Tablet
Combiflam-A, a dual-action formulation, addresses abdominal pain. It alleviates abdominal pain, distension, discomfort, and spasms by inducing relaxation in the gastrointestinal tract's musculature. Simultaneously, it inhibits specific neurotransmitters responsible for pain signals. Combiflam-A should be ingested with meals, following the physician's prescribed dosage and duration. Dosage is individualized, adapting to your response and condition. Continue the prescribed regimen; premature cessation may lead to symptom recurrence and potential exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common side effects include diarrhea, nausea, vomiting, abdominal pain, xerostomia, anorexia, thirst, and pyrosis. These are usually transient and self-limiting. Report any concerning side effects immediately. Dizziness and somnolence are possible; refrain from driving or activities requiring alertness until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician before commencing treatment. Similarly, inform your doctor of any renal or hepatic impairment to ensure appropriate dosage.
Primary Ingredients of Drotiphar-M Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased. Therefore, no rewritten text can be provided.
Uses of Drotiphar-M Tablet
Managing abdominal discomfort
Major Benefits of Drotiphar-M Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Drotiphar-M Tablet with a meal.
Common Side effects of Drotiphar-M Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Drotiphar-M Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Drotiphar-M Tablet with a meal.
How Drotiphar-M Tablet works:
Drotaverine and mefenamic acid, combined in Drotiphar-M tablets, offer relief from abdominal pain and cramping. Drotaverine acts as an antispasmodic, easing painful muscle contractions in the abdomen. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), reduces pain and inflammation by inhibiting the production of substances that trigger these symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Combining Drotiphar-M Tablet and alcohol is contraindicated due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Drotiphar-M Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Drotiphar-M Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Drotiphar-M Tablets may induce adverse reactions that could impair driving ability, such as vertigo.
KidneyCAUTION
Exercise caution when administering Drotiphar-M tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Drotiphar-M tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Drotiphar-M Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Drotiphar-M Tablet :
Should you forget a Drotiphar-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Drotiphar-M Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
